Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies

Mohit Chouhan September 04, 2021
Celsion (CLSN) announces data from pre-clinical studies for its investigational vaccine platform as a potential treatment for COVID-19.


Post a Comment

0 Comments